A team of virologists, infectious disease experts and immunologists at McMaster is developing two new second-generation COVID-19 vaccine candidates, designing and producing them in a specialized facility on campus.
The ability to manufacture a vaccine puts McMaster among a very small number of research facilities attempting to fill the made-in-Canada gap in the race to produce more vaccines….